Condition

Rare Cancer

ClinicalTrials.gov condition label

Clinical trials4

Recruiting3

Common interventions1

Lead sponsors shown2

Clinical trials

4 shown

Study of High-Precision Evaluation of Molecular ResiduaL Disease Through a PlatfOrm for Cancer TracKing and Interception (SHERLOCK)NCT07524114 · 2026-03-31

RECRUITING

Ontario-wide Cancer TArgeted Nucleic Acid EvaluationNCT02906943 · 2016-08-01

RECRUITING

Genomic Investigation of Unusual RespondersNCT03740503 · 2013-11-01

RECRUITING

Attention and Interpretation Modification (AIM) for Fear of Cancer Recurrence: An Intervention Development StudyNCT01517945 · 2012-01-01

ACTIVE_NOT_RECRUITING

Common interventions

AIM materials and assessmentsBEHAVIORAL1

Leading sponsors

University Health Network, Toronto3Memorial Sloan Kettering Cancer Center1

Trial status mix

RECRUITING3

ACTIVE_NOT_RECRUITING1

Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.